Skip to content

Dyne 制药

US · DYN #2540 按市值排名 上市于 2020
14.25 -1.04 -6.80%
实时 - 追踪5344个代码 - 心跳于406秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了1家。
  • 机构持股总比例下降了15.4个百分点。

机构持股

机构持股比例
100.80% -15.43pp
机构数量
291 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund66.63%
VC/PE Fund17.60%
Hedge Fund12.25%
Public Company3.30%
Government Pension Fund0.61%
Individual/Insider0.27%
Private Company0.18%
Insurance Company0.11%

主要股东 截至 2026-06-30

T. Rowe Price Group, Inc. 18.66% · 34.85M 股
BlackRock 6.64% · 12.40M 股
Janus Henderson Group plc 6.42% · 12.00M 股
FMR 6.00% · 11.21M 股
State Street Global Advisors 3.99% · 7.46M 股
Vanguard Capital Management, LLC 3.91% · 7.30M 股
Orbis Investment Management Limited 3.75% · 7.01M 股
TCG Crossover Management, LLC 2.47% · 4.62M 股
Vanguard Portfolio Management, LLC 2.17% · 4.05M 股
Geode Capital Management, LLC 2.00% · 3.74M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 14次买入 · 36次卖出

姓名职务持股比例
John Cox Chief Executive Officer 0.10%
Catherine Stehman-Breen Independent Director 0.05%
Oxana Beskrovnaya Chief Scientific Officer 0.04%
Johanna Friedl-Naderer Chief Commercial Officer 0.03%
Douglas Kerr Chief Medical Officer 0.02%
Brian Posner Director 0.01%
Richard Scalzo Senior VP and Head of Finance & Administration 0.01%
Erick Lucera CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer 0.01%
Atlas Venture Advisors, Inc. -- --
Edward Hurwitz Independent Director --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-07 Douglas Kerr Chief Medical Officer Automatic Disposition -5,035 $18.88–24.35
2026-09-07 Douglas Kerr Chief Medical Officer Intent to Sell (Form 144) -35 $18.89
2026-09-07 John Cox Chief Executive Officer Automatic Disposition -5,658 $18.88
2026-09-07 Johanna Friedl-Naderer Chief Commercial Officer Automatic Disposition -1,085 $18.88–24.35
2026-09-03 Douglas Kerr Chief Medical Officer Intent to Sell (Form 144) -5,000 $24.35
2026-08-13 Atlas Venture Advisors, Inc. -- Automatic Disposition -2,586,928 $25.00–26.20
2026-08-12 Douglas Kerr Chief Medical Officer Automatic Disposition -1,556 $26.28
2026-08-12 John Cox Chief Executive Officer Automatic Disposition -4,986 $26.28
2026-08-12 Erick Lucera CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer Automatic Disposition -1,797 $26.28
2026-08-12 Johanna Friedl-Naderer Chief Commercial Officer Automatic Disposition -226 $26.28
2026-07-26 Forbion Capital Partners B.V. -- Automatic Disposition -261,460 $25.50–26.04
2026-07-06 Atlas Venture Advisors, Inc. -- Automatic Disposition -772,451 $22.79–23.62
2026-07-06 Atlas Venture Advisors, Inc. -- Open Market Disposition -5,000 $23.61
2026-06-28 Atlas Venture Advisors, Inc. -- Automatic Disposition -504,695 $21.14–21.28
2026-06-24 Atlas Venture Advisors, Inc. -- Automatic Disposition -267,760 $21.02–21.13
2026-06-24 Erick Lucera CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer Open Market Disposition -2,362 $20.37
2026-06-22 Forbion Capital Partners B.V. -- Automatic Disposition -263,962 $20.57–21.47
2026-06-21 Barry Greene Independent Director Other Derivative Acquisition +57,463 $20.87
2026-06-17 Forbion Capital Partners B.V. -- Automatic Disposition -84,355 $20.07–20.14
2026-06-16 Forbion Capital Partners B.V. -- Intent to Sell (Form 144) -348,317 $18.33

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

Dyne 制药 讨论区 0 条评论

发表评论